Endra Life Sciences Inc (NDRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 1,371 | 1,301 | 1,469 | 4,297 | 1,509 |
| Operating Income | -1,371 | -1,301 | -1,469 | -4,297 | -1,509 |
| Other Income | -225 | 75 | 433 | 148 | -845 |
| Pre-tax Income | -1,596 | -1,226 | -1,036 | -4,149 | -2,354 |
| Net Income Continuous | -1,596 | -1,226 | -1,036 | -4,149 | -2,354 |
| Net Income | $-1,596 | $-1,226 | $-1,036 | $-4,149 | $-2,354 |
| EPS Basic Total Ops | -2.10 | -1.71 | -1.86 | 402.26 | -9.54 |
| EPS Basic Continuous Ops | -2.10 | -1.71 | -1.86 | 554.50 | -9.53 |
| EPS Diluted Total Ops | -2.10 | -1.71 | -1.86 | 402.26 | -9.54 |
| EPS Diluted Continuous Ops | -2.10 | -1.71 | -1.86 | 554.50 | -9.53 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.71 | -2.59 | -9.40 | -5.85 |
| EBITDA(a) | $-1,331 | $-1,268 | $-1,424 | $-4,250 | $-1,455 |